175P Radiomic biomarker of vessel tortuosity for monitoring treatment change: Preliminary findings in prospective evaluation of ECOG-ACRIN EA5163
Pritesh Mutha(The Wallace H. Coulter Department of Biomedical Engineering), Anant Madabhushi(Emory University), Fenghai Duan(Brown University), Kim L. Sandler(Vanderbilt University), Amit Gupta(University of Washington), Vamsidhar Velcheti(Cleveland Clinic), Karen Kelly(Cancer Research Center), Suresh S. Ramalingam(Emory University), Ning An(China Coal Research Institute (China)), Hossein Borghaei(Fox Chase Cancer Center), Vidya Sankar Viswanathan(Case Western Reserve University), Mohammadhadi Khorrami(Case Western Reserve University)
Cited by 1
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835